- Report
- August 2025
- 150 Pages
Global
From €2966EUR$3,358USD£2,599GBP
€3489EUR$3,950USD£3,057GBP
- Report
- August 2025
- 150 Pages
Global
From €2966EUR$3,358USD£2,599GBP
€3489EUR$3,950USD£3,057GBP
- Report
- October 2025
- 89 Pages
Global
From €4284EUR$4,850USD£3,754GBP
- Report
- August 2025
- 122 Pages
North America
From €2252EUR$2,549USD£1,973GBP
€2649EUR$2,999USD£2,321GBP
- Report
- May 2023
- 159 Pages
Global
From €2076EUR$2,350USD£1,819GBP
- Report
- June 2023
- 150 Pages
Global
From €5256EUR$5,950USD£4,605GBP
- Report
- January 2024
- 200 Pages
Global
From €3666EUR$4,150USD£3,212GBP
- Report
- February 2024
- 130 Pages
Global
From €4196EUR$4,750USD£3,676GBP
- Report
- April 2023
- 110 Pages
Global
From €4196EUR$4,750USD£3,676GBP
- Report
- April 2023
- 120 Pages
Global
From €4196EUR$4,750USD£3,676GBP
- Report
- July 2021
- 111 Pages
Global
From €4196EUR$4,750USD£3,676GBP
- Report
- July 2024
- 80 Pages
United Kingdom
From €4196EUR$4,750USD£3,676GBP
- Report
- February 2024
- 80 Pages
India
From €4196EUR$4,750USD£3,676GBP
- Report
- February 2025
- 85 Pages
India
From €3092EUR$3,500USD£2,709GBP
- Report
- September 2024
- 80 Pages
Saudi Arabia
From €3092EUR$3,500USD£2,709GBP
- Report
- August 2024
- 82 Pages
Japan
From €3092EUR$3,500USD£2,709GBP
- Report
- May 2022
- 163 Pages
Global
From €3180EUR$3,600USD£2,786GBP
- Report
- November 2023
- 150 Pages
Global
From €3401EUR$3,850USD£2,980GBP
€4284EUR$4,850USD£3,754GBP
- Report
- April 2023
- 147 Pages
Global
From €4372EUR$4,949USD£3,830GBP
- Report
- October 2025
- 115 Pages
Spain
From €2675EUR$3,244USD£2,426GBP

The Over the Counter (OTC) Analgesics market is a segment of the OTC Drugs industry that focuses on providing relief from pain and discomfort. These products are available without a prescription and are typically used to treat mild to moderate pain. Common OTC analgesics include acetaminophen, ibuprofen, and aspirin. These products are available in a variety of forms, such as tablets, capsules, liquids, and topical creams.
The OTC Analgesics market is highly competitive, with a wide range of products available from both large and small companies. Major players in the market include Bayer, Pfizer, Johnson & Johnson, GlaxoSmithKline, and Novartis. Other companies in the market include Perrigo, Prestige Brands, and Sun Pharmaceuticals. Show Less Read more